Medicines Australia restarts NMP review

Medicines Australia's national medicines policy (NMP) review, which was put on hold before the country's May federal election, has restarted.

The decision to place the review on hold was influenced by stakeholders agreeing that four weeks was not enough time to provide feedback on the draft, which was released in February 2022.

Aiming to deliver positive health outcomes for all Australians through their access to and appropriate use of medicines, the review provides a well-established and universally endorsed framework based on partnerships between consumers and all segments of the medicines sector, with the last review being published in 2000.